Zobrazeno 1 - 10
of 169
pro vyhledávání: '"Wildgoose, Peter"'
Autor:
Khorana, Alok A. *, Barnard, John, Wun, Ted, Vijapurkar, Ujjwala, Damaraju, CV, Moore, Kenneth Todd, Wildgoose, Peter, McCrae, Keith R.
Publikováno v:
In Blood Advances 22 February 2022 6(4):1212-1221
Autor:
Kerneis, Mathieu, Gibson, C. Michael, Chi, Gerald, Mehran, Roxana, AlKhalfan, Fahad, Talib, Usama, Pahlavani, Seyedmahdi, Mir, Mahshid, Bode, Christoph, Halperin, Jonathan L., Nafee, Tarek, Peterson, Eric D., Verheugt, Freek W.A., Wildgoose, Peter, van Eickels, Martin, Lip, Gregory Y.H., Fox, Keith A.A., Cohen, Marc
Publikováno v:
In JACC: Cardiovascular Interventions 9 April 2018 11(7):626-634
Autor:
Khorana, Alok A., Berger, Jeffrey S., Wells, Philip S., Seheult, Roger, Ashton, Veronica, Laliberté, François, Crivera, Concetta, Lejeune, Dominique, Schein, Jeff, Wildgoose, Peter, Lefebvre, Patrick, Kaatz, Scott
Publikováno v:
In Clinical Therapeutics July 2017 39(7):1396-1408
Autor:
Nelson, Winnie W., Choi, Jiyoon C., Vanderpoel, Julie, Damaraju, Chandrasekharra V., Wildgoose, Peter, Fields, Larry E., Schein, Jeffrey R.
Publikováno v:
In The American Journal of Cardiology 15 August 2013 112(4):509-512
Publikováno v:
In Thrombosis Research November 2012 130(5):709-715
Autor:
Chi, Gerald, Allaham, Laith, Molina, Alberto Castro, Korjian, Serge, Jiang, Ginger Y., Daaboul, Yazan, Bahit, Maria Cecilia, Wildgoose, Peter, Plotnikov, Alexei, Dangas, Christiana, Mehran, Roxana, Gibson, C. Michael
Publikováno v:
In Journal of the American College of Cardiology 2 April 2024 83(13) Supplement:1148-1148
Autor:
Mones, Jodi V., Streiff, Michael B., Khorana, Alok A., Bendheim, Gemma A., Damaraju, C.V., Wildgoose, Peter, Burton, Paul, Riess, Hanno, Soff, Gerald A. *
Publikováno v:
In Research and Practice in Thrombosis and Haemostasis July 2021 5(5)
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 1990 Sep 01. 87(18), 7290-7294.
Externí odkaz:
https://www.jstor.org/stable/2355210
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Dangas, George D., Tijssen, Jan G. P., Wöhrle, Jochen, Søndergaard, Lars, Gilard, Martine, Möllmann, Helge, Makkar, Raj R., Herrmann, Howard C., Giustino, Gennaro, Baldus, Stephan, de Backer, Ole, Guimarães, Ana H. C., Gullestad, Lars, Kini, Annapoorna, von Lewinski, Dirk, Mack, Michael, Moreno, Raúl, Schäfer, Ulrich, Seeger, Julia, Tchétché, Didier, Thomitzek, Karen, Valgimigli, Marco, Vranckx, Pascal, Welsh, Robert C., Wildgoose, Peter, Volkl, Albert A., Zazula, Ana, van Amsterdam, Ronald G. M., Mehran, Roxana, Windecker, Stephan, Dangas, G. D., Windecker, S., Mehran, R., Tijssen, J. G. P., Welsh, R. C., Vranckx, P., Valgimigli, M., van Amsterdam, R. G. M., Thomitzek, K., Wildgoose, P., Colombo, A., Prendergast, B., Makkar, R., Mack, M., Webb, J., Marx, Steven O., Corvaja, Nicola, Ghodsi, Newsha, DiStefano, Douglas, Kaufman, David
Publikováno v:
Dangas, George D; Tijssen, Jan G P; Wöhrle, Jochen; Søndergaard, Lars; Gilard, Martine; Möllmann, Helge; Makkar, Raj R; Herrmann, Howard C; Giustino, Gennaro; Baldus, Stephan; De Backer, Ole; Guimarães, Ana H C; Gullestad, Lars; Kini, Annapoorna; von Lewinski, Dirk; Mack, Michael; Moreno, Raúl; Schäfer, Ulrich; Seeger, Julia; Tchétché, Didier; ... (2020). A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement. The New England journal of medicine, 382(2), pp. 120-129. Massachusetts Medical Society 10.1056/NEJMoa1911425
Article
Dipòsit Digital de la UB
Universidad de Barcelona
New England journal of medicine, 382(2), 120-129. Massachussetts Medical Society
Dangas, G D, Tijssen, J G P, Wöhrle, J, Søndergaard, L, Gilard, M, Möllmann, H, Makkar, R R, Herrmann, H C, Giustino, G, Baldus, S, De Backer, O, Guimarães, A H C, Gullestad, L, Kini, A, von Lewinski, D, Mack, M, Moreno, R, Schäfer, U, Seeger, J, Tchétché, D, Thomitzek, K, Valgimigli, M, Vranckx, P, Welsh, R C, Wildgoose, P, Volkl, A A, Zazula, A, van Amsterdam, R G M, Mehran, R, Windecker, S & GALILEO Investigators 2020, ' A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement ', The New England Journal of Medicine, vol. 382, no. 2, pp. 120-129 . https://doi.org/10.1056/NEJMoa1911425
Dangas, G D, Tijssen, J G P, Wöhrle, J, Søndergaard, L, Gilard, M, Möllmann, H, Makkar, R R, Herrmann, H C, Giustino, G, Baldus, S, de Backer, O, Guimarães, A H C, Gullestad, L, Kini, A, von Lewinski, D, Mack, M, Moreno, R, Schäfer, U, Seeger, J, Tchétché, D, Thomitzek, K, Valgimigli, M, Vranckx, P, Welsh, R C, Wildgoose, P, Volkl, A A, Zazula, A, van Amsterdam, R G M, Mehran, R, Windecker, S & GALILEO Investigators 2020, ' A controlled trial of rivaroxaban after transcatheter aortic-valve replacement ', New England Journal of Medicine, vol. 382, no. 2, pp. 120-129 . https://doi.org/10.1056/NEJMoa1911425
Article
Dipòsit Digital de la UB
Universidad de Barcelona
New England journal of medicine, 382(2), 120-129. Massachussetts Medical Society
Dangas, G D, Tijssen, J G P, Wöhrle, J, Søndergaard, L, Gilard, M, Möllmann, H, Makkar, R R, Herrmann, H C, Giustino, G, Baldus, S, De Backer, O, Guimarães, A H C, Gullestad, L, Kini, A, von Lewinski, D, Mack, M, Moreno, R, Schäfer, U, Seeger, J, Tchétché, D, Thomitzek, K, Valgimigli, M, Vranckx, P, Welsh, R C, Wildgoose, P, Volkl, A A, Zazula, A, van Amsterdam, R G M, Mehran, R, Windecker, S & GALILEO Investigators 2020, ' A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement ', The New England Journal of Medicine, vol. 382, no. 2, pp. 120-129 . https://doi.org/10.1056/NEJMoa1911425
Dangas, G D, Tijssen, J G P, Wöhrle, J, Søndergaard, L, Gilard, M, Möllmann, H, Makkar, R R, Herrmann, H C, Giustino, G, Baldus, S, de Backer, O, Guimarães, A H C, Gullestad, L, Kini, A, von Lewinski, D, Mack, M, Moreno, R, Schäfer, U, Seeger, J, Tchétché, D, Thomitzek, K, Valgimigli, M, Vranckx, P, Welsh, R C, Wildgoose, P, Volkl, A A, Zazula, A, van Amsterdam, R G M, Mehran, R, Windecker, S & GALILEO Investigators 2020, ' A controlled trial of rivaroxaban after transcatheter aortic-valve replacement ', New England Journal of Medicine, vol. 382, no. 2, pp. 120-129 . https://doi.org/10.1056/NEJMoa1911425
Background Whether the direct factor Xa inhibitor rivaroxaban can prevent thromboembolic events after transcatheter aortic-valve replacement (TAVR) is unclear. Methods We randomly assigned 1644 patients without an established indication for oral anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90c3ae5ab6f694fae00da8d0f58ce2f3